CLTS - Earth Life Sciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
Operating expenses
Selling general and administrative
379.832
1,563
1,828
53.288
Total operating expenses
379.832
1,563
1,828
53.778
Operating income or loss
-379.832
-1,563
-1,828
-53.778
Interest expense
17.312
21.53
-
-
Income before tax
-397.144
-1,584
-1,828
-53.778
Income from continuing operations
-397.144
-1,584
-1,828
-53.778
Net income
-397.144
-1,584
-1,828
-53.778
Net income available to common shareholders
-397.144
-1,584
-1,828
-53.778
Basic EPS
-
-0.00
-0.00
-0.00
Diluted EPS
-
-0.00
-0.00
-0.00
Basic average shares
-
494,645
438,475
332,988
Diluted average shares
-
494,645
438,475
332,988
EBITDA
-
-1,563
-1,828
-53.288